This review evaluates the physiological significance of PYY in glucose homeostasis, synthesizing current data from preclinical and clinical T2D research, and drawing direct comparisons with GLP-1 regarding receptor selectivity, metabolic efficacy, and adverse event profiles. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.